It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
An outbreak of SARS-CoV-2 (1 March to 10 May 2021) with an attack rate of 26.5% among approximately 1150 workers at a storage and distribution centre in England prompted a multidisciplinary outbreak investigation (5 May to 6 August 2021), with the aim of better understanding worker- and workplace-related risk factors for viral transmission in the warehousing sector. Overall, environmental factors (e.g., ventilation, humidity and temperature) were assessed to be appropriate at the facility. Nevertheless, 39 (51.3%) surface samples from across the site tested positive for low/ very low levels of SARS-CoV-2 RNA (Ct value ≥ 32.0 for all). Among the study participants, of whom 35.6% were confirmed or suspected cases, 95.5% reported having received COVID-19 prevention training, 100.0% reported handwashing, and 80.0% reported use of face coverings at work. Notably, 43.9% and 19.0% reported working with a symptomatic and a positive contact respectively. Furthermore, 80.5% and 46.3% had concerns regarding reduction in their income and future unemployment, respectively, due to self-isolation. The findings of this study suggest that, in addition to targeted workplace infection control measures and tailored work area specific risk assessments, an enhanced and equitable sick leave policy may help limit presenteeism and viral transmission in large workplaces.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 London School of Hygiene & Tropical Medicine, Health Equity Action Lab, Department of Infectious Disease Epidemiology, London, UK (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X)
2 Health and Safety Executive, Science Division, Buxton, UK (GRID:grid.9984.c)
3 London School of Hygiene & Tropical Medicine, Department of Non-Communicable Disease Epidemiology, London, UK (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X)
4 UK Health Security Agency, Research and Evaluation, Salisbury, UK (GRID:grid.9984.c)
5 UK Health Security Agency, Rapid Investigation Team, Field Services, London, UK (GRID:grid.9984.c)
6 UK Health Security Agency, Chemical and Environmental Effects Department, Chilton, UK (GRID:grid.9984.c)
7 London School of Hygiene & Tropical Medicine, Department of Medical Statistics, London, UK (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X)